Brief: Vivani Medical Announces FDA Clears Investigational New Drug Application And Lifts Clinical Hold For NPM-119, A Miniature Long-Term Subdermal Glp-1 Drug Implant
13/06/2024 13:42
June 13 (Reuters) - Vivani Medical Inc VANI.O :
* VIVANI MEDICAL ANNOUNCES FDA CLEARS INVESTIGATIONAL NEW
DRUG
APPLICATION AND LIFTS CLINICAL HOLD FOR NPM-119, A MINIATURE
LONG-TERM SUBDERMAL GLP-1 DRUG IMPLANT
Source text for Eikon: ID:nBw5qPBQta
Further company coverage: VANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivani Medical
See all newsVivani Medical Q2 net loss narrows as expenses fall
Vivani Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Vivani Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia